Scientists hunt for clues to predict dangerous drug reactions in breast cancer patients
NCT ID NCT07049133
Summary
This study aims to find markers in the blood that might predict which patients with advanced breast cancer are more likely to experience serious side effects from the drug T-DXd. Researchers will observe 84 patients receiving this standard treatment and collect their blood samples to look for these clues. The goal is to help doctors better manage treatment and improve safety for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
European Institute of Oncolgy
RECRUITINGMilan, 20141, Italy
Contact
Conditions
Explore the condition pages connected to this study.